MimiVax, Inc. is developing immunotherapeutic vaccines and targeted therapies for treating cancers and preventing recurrence. The company’s lead agent, SurVaxM, targets survivin, a cell-survival ...
A new study published by Pharmaceutics finds that the cannabis compound cannabidiol, better known as CBD, could enhance the ...
As of Monday, December 29, Inovio Pharmaceuticals, Inc.’s INO share price has dipped by 19.87%, which has investors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback